Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 176,677 | 144,413 | N/A |
| Marketable Securities | 50,248 | N/A | N/A |
| Receivables | 3,481 | 2,116 | N/A |
| TOTAL | $233,309 | $148,214 | $N/A |
| Non-Current Assets | |||
| PPE Net | 23,269 | 4,265 | N/A |
| Intangibles | 14,097 | 0 | 0 |
| Other Non-Current Assets | 6,299 | 232 | 0 |
| TOTAL | $43,665 | $4,498 | $N/A |
| Total Assets | $276,974 | $152,712 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,329 | 615 | 0 |
| Accrued Expenses | 620 | 300 | N/A |
| TOTAL | $5,835 | $1,616 | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 2,386 | 220 | N/A |
| TOTAL | $1,665 | $2,312 | $N/A |
| Total Liabilities | $7,500 | $3,928 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 2,759 | N/A | N/A |
| Common Shares | 3 | 2 | N/A |
| Retained earnings | -27,574 | -20,691 | N/A |
| Other shareholders' equity | -3,605 | -7,900 | 0 |
| TOTAL | $269,474 | $148,784 | $N/A |
| Total Liabilities And Equity | $276,974 | $152,712 | $0 |